These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7984152)

  • 21. Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol.
    Ignar-Trowbridge DM; Pimentel M; Parker MG; McLachlan JA; Korach KS
    Endocrinology; 1996 May; 137(5):1735-44. PubMed ID: 8612509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential effects of insulin-like growth factor (IGF)-I and IGF-II on the expression of IGF binding proteins (IGFBPs) in a rat neuroblastoma cell line: isolation and characterization of two forms of IGFBP-4.
    Ceda GP; Fielder PJ; Henzel WJ; Louie A; Donovan SM; Hoffman AR; Rosenfeld RG
    Endocrinology; 1991 Jun; 128(6):2815-24. PubMed ID: 1709857
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The oestrogen receptor modulates growth of pituitary tumour cells in the absence of exogenous oestrogen.
    Newton CJ; Trapp T; Pagotto U; Renner U; Buric R; Stalla GK
    J Mol Endocrinol; 1994 Jun; 12(3):303-12. PubMed ID: 7916969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Luteinizing hormone-releasing hormone antagonists interfere with autocrine and paracrine growth stimulation of MCF-7 mammary cancer cells by insulin-like growth factors.
    Hershkovitz E; Marbach M; Bosin E; Levy J; Roberts CT; LeRoith D; Schally AV; Sharoni Y
    J Clin Endocrinol Metab; 1993 Oct; 77(4):963-8. PubMed ID: 8408472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II.
    Braczkowski R; Schally AV; Plonowski A; Varga JL; Groot K; Krupa M; Armatis P
    Cancer; 2002 Oct; 95(8):1735-45. PubMed ID: 12365022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factor I receptor prevents apoptosis and enhances neuroblastoma tumorigenesis.
    Singleton JR; Randolph AE; Feldman EL
    Cancer Res; 1996 Oct; 56(19):4522-9. PubMed ID: 8813151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin-like growth factor-II expression is down-regulated in TrkA-transfected SK-N-AS neuroblastoma cells.
    Kim CJ; Chi JG; Thiele CJ
    Lab Invest; 1999 Aug; 79(8):1007-13. PubMed ID: 10462038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Divergent pathways regulate ligand-independent activation of ER alpha in SK-N-BE neuroblastoma and COS-1 renal carcinoma cells.
    Patrone C; Gianazza E; Santagati S; Agrati P; Maggi A
    Mol Endocrinol; 1998 Jun; 12(6):835-41. PubMed ID: 9626659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ; Jordan VC
    Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Estrogenic control of monoamine oxidase A activity in human neuroblastoma cells expressing physiological concentrations of estrogen receptor.
    Ma ZQ; Violani E; Villa F; Picotti GB; Maggi A
    Eur J Pharmacol; 1995 Sep; 284(1-2):171-6. PubMed ID: 8549621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of insulin and insulin-like growth factors on neurofilament mRNA and tubulin mRNA content in human neuroblastoma SH-SY5Y cells.
    Wang C; Li Y; Wible B; Angelides KJ; Ishii DN
    Brain Res Mol Brain Res; 1992 May; 13(4):289-300. PubMed ID: 1320719
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The estrogen receptor's involvement in osteoblasts' adaptive response to mechanical strain.
    Damien E; Price JS; Lanyon LE
    J Bone Miner Res; 1998 Aug; 13(8):1275-82. PubMed ID: 9718196
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection.
    Cardona-Gómez GP; Mendez P; DonCarlos LL; Azcoitia I; Garcia-Segura LM
    Brain Res Brain Res Rev; 2001 Nov; 37(1-3):320-34. PubMed ID: 11744097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insulin-like growth factor binding proteins-2 and -3 stimulate growth hormone receptor binding and mitogenesis in rat osteosarcoma cells.
    Slootweg MC; Ohlsson C; Salles JP; de Vries CP; Netelenbos JC
    Endocrinology; 1995 Oct; 136(10):4210-7. PubMed ID: 7545101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor I shifts from promoting cell division to potentiating maturation during neuronal differentiation.
    Påhlman S; Meyerson G; Lindgren E; Schalling M; Johansson I
    Proc Natl Acad Sci U S A; 1991 Nov; 88(22):9994-8. PubMed ID: 1946468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanical strain stimulates osteoblast proliferation through the estrogen receptor in males as well as females.
    Damien E; Price JS; Lanyon LE
    J Bone Miner Res; 2000 Nov; 15(11):2169-77. PubMed ID: 11092397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin-like growth factors I and II are autocrine factors in stimulating proteoglycan synthesis, a marker of differentiated chondrocytes, acting through their respective receptors on a clonal human chondrosarcoma-derived chondrocyte cell line, HCS-2/8.
    Takigawa M; Okawa T; Pan H; Aoki C; Takahashi K; Zue J; Suzuki F; Kinoshita A
    Endocrinology; 1997 Oct; 138(10):4390-400. PubMed ID: 9322955
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response of bipotential human marrow stromal cells to insulin-like growth factors: effect on binding protein production, proliferation, and commitment to osteoblasts and adipocytes.
    Thomas T; Gori F; Spelsberg TC; Khosla S; Riggs BL; Conover CA
    Endocrinology; 1999 Nov; 140(11):5036-44. PubMed ID: 10537129
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IGFBPs are involved in xenograft development in nude mice.
    Babajko S; Grellier P; de Gallé B; Menouny M; Binoux M
    Med Pediatr Oncol; 2001 Jan; 36(1):154-6. PubMed ID: 11464872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-like growth factors modulate the growth inhibitory effects of retinoic acid on MCF-7 breast cancer cells.
    Bentel JM; Lebwohl DE; Cullen KJ; Rubin MS; Rosen N; Mendelsohn J; Miller WH
    J Cell Physiol; 1995 Oct; 165(1):212-21. PubMed ID: 7559803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.